Close Menu

Sometimes after seeing an initial interesting result from a project, that trend or its significance peters off in replication studies, leading a New Yorker article from Jonah Lehrer to wonder if there is something wrong with the scientific method. The decline, Lehrer says, is partially explained by publication bias or selective reporting, but the rest of the explanation may be due to randomness or noise. "This suggests that the decline effect is a decline of illusion," Lehrer says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.